Disclosed herein are compositions comprising an NSAID such as meloxicamin combination with cyclodextrin and/or a carbonate or a bicarbonate. Thesecompositionsmay be orally administered, for example, to improve the bioavailability orpharmacokineticsof the NSAID for the treatment of conditions such as pain.